
Penn Medicine is no longer offering gender-affirming surgical procedures to patients under the age of 19, the health system confirmed to NBC Philadelphia on Thursday. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading.
Main Idea: Penn Medicine says it will stop offering gender-affirming surgical procedures to patients under 19 because of federal guidance linked to President Donald Trump’s administration.
Key Points:
Families with transgender teens may lose access to surgical care at Penn Medicine, adding stress, travel costs, and delays for patients and doctors.
Some people who back the federal limits may see the policy as clearer compliance for hospitals and lower legal risk.
Rate how each entity in this article affected the American people.
No entity suggestions or linked entities saved yet.
Federal department whose civil rights office investigated Penn and whose actions are part of the story.
Penn Medicine chief medical officer quoted explaining and defending the institution’s decision.
His administration’s federal guidance and executive order are a central driver of the change described in the article.
Central federal body involved in the investigation referenced in the article.
The article discusses the university’s related clash with the Trump administration and funding suspension.
Named transgender athlete used as part of the broader context for the federal dispute with Penn.
Philadelphia City Councilmember quoted criticizing Penn Medicine’s decision.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentLocal governing body indirectly represented through Councilmember Rue Landau’s comments.